Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
Abstract Precision medicine for alcohol use disorder (AUD) allows optimal treatment of the right patient with the right drug at the right time. Here, we generated multivariable models incorporating clinical information and serum metabolite levels to predict acamprosate treatment response. The sample...
Guardado en:
Autores principales: | David J. Hinton, Marely Santiago Vázquez, Jennifer R. Geske, Mario J. Hitschfeld, Ada M. C. Ho, Victor M. Karpyak, Joanna M. Biernacka, Doo-Sup Choi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d17a8ba0a08e49ca9953eacbb578a883 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New biomarkers of coffee consumption identified by the non-targeted metabolomic profiling of cohort study subjects.
por: Joseph A Rothwell, et al.
Publicado: (2014) -
Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Kamil Borkowski, et al.
Publicado: (2021) -
Metabolomic biomarkers in serum and urine in women with preeclampsia.
por: Marie Austdal, et al.
Publicado: (2014) -
Plasma metabolomic profiling reveals potential onset of lay biomarkers in broiler breeders
por: Mohammad Afrouziyeh, et al.
Publicado: (2022) -
Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
por: José Luis Izquierdo-Garcia, et al.
Publicado: (2020)